Funding for this research was provided by:
Centers for Disease Control and Prevention (U48DP005013)
Received: 4 February 2020
Accepted: 31 August 2020
First Online: 15 September 2020
Ethics approval and consent to participate
: All study documents were reviewed and approved by the University of Washington Institutional Review Board (protocol number 00000472); a waiver of informed consent was obtained given minimal risks imposed to study participants.
: Not applicable.
: From September 2017 to June 2018, Dr. Coronado served as the Principal Investigator on a contract awarded to the Kaiser Permanente Center for Health Research to compare the clinical performance of an experimental fecal immunochemical test (FIT) to an FDA-approved FIT. This study is funded by Quidel Corporation. From July 2020 to persent, Dr. Coronado has serve as a scientific advisor for Exact Sciences. From February 2016 to July 2018, Jennifer Coury was contracted with CareOregon, Inc. to improve colorectal cancer screening rates in health plan members, including coordination of a mailed FIT program and coordination with the research team. From September 2019 to June 2020, Dr. Green served as a Co-investigator on a contract awarded to the Kaiser Foundation Health Plan of Washington from Amgen to evaluate the accuracy of using electronic health record data to identify individuals with reduced ejection fraction heart failure. The other authors declare that they have no competing interests.